Alkın Yazıcıoğlu1, Erdal Yekeler1, Ülkü Yazıcı2, Ertan Aydın3, İrfan Taştepe4, Nurettin Karaoğlanoğlu2. 1. Clinic of Chest Surgery and Lung Transplantation, Türkiye High Specialization Training and Research Hospital, Ankara, Turkey. 2. Clinic of Chest Surgery, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey. 3. Clinic of Chest Surgery, Koru Private Hospital, Ankara, Turkey. 4. Department of Chest Surgery, Gazi University Faculty of Medicine, Ankara, Turkey.
Abstract
OBJECTIVES: The objective was to describe changing patterns of etiological factors and treatment modalities for massive hemoptysis. MATERIAL AND METHODS: From January 2008-December 2012, the medical records of 58 massive hemoptysis patients were reviewed. RESULTS: Fifty-eight patients, 44 were men (75.9%) and 14 were women (24.1%), with a mean age of 51.4 years (range= 19-84 years), were divided into three groups; surgical management (n= 37, 63.8%), conservative management (n= 14, 24.1%) and bronchial artery embolization (n= 6, 10.4%). One case (1.7%) had combined treatment modality; bronchial artery embolization was followed by surgical resection. Anatomical lung resections were the most preferred resection type in the surgical management group (n= 34, 91.9%). The most common etiological factor was bronchiectasis (n= 19, 32.8%); followed by bronchial cancer (n= 14, 24.1%). The duration of hospitalization in the surgical management group was 11.4 days (range= 4-24); whereas in the bronchial artery embolization group, hospitalization was only four days (range= 2-7) (p< 0.01). Prolonged air leak (n= 7; 18.9%) was the most common complication in the surgical management group. CONCLUSION: We emphasize that bronchiectasis was leading cause of massive hemoptysis. Surgical treatment remains the definitive therapy in the management of massive hemoptysis with decreased mortality rates over decades; whereas bronchial artery embolization is an effective therapeutic tool.
OBJECTIVES: The objective was to describe changing patterns of etiological factors and treatment modalities for massive hemoptysis. MATERIAL AND METHODS: From January 2008-December 2012, the medical records of 58 massive hemoptysispatients were reviewed. RESULTS: Fifty-eight patients, 44 were men (75.9%) and 14 were women (24.1%), with a mean age of 51.4 years (range= 19-84 years), were divided into three groups; surgical management (n= 37, 63.8%), conservative management (n= 14, 24.1%) and bronchial artery embolization (n= 6, 10.4%). One case (1.7%) had combined treatment modality; bronchial artery embolization was followed by surgical resection. Anatomical lung resections were the most preferred resection type in the surgical management group (n= 34, 91.9%). The most common etiological factor was bronchiectasis (n= 19, 32.8%); followed by bronchial cancer (n= 14, 24.1%). The duration of hospitalization in the surgical management group was 11.4 days (range= 4-24); whereas in the bronchial artery embolization group, hospitalization was only four days (range= 2-7) (p< 0.01). Prolonged air leak (n= 7; 18.9%) was the most common complication in the surgical management group. CONCLUSION: We emphasize that bronchiectasis was leading cause of massive hemoptysis. Surgical treatment remains the definitive therapy in the management of massive hemoptysis with decreased mortality rates over decades; whereas bronchial artery embolization is an effective therapeutic tool.
Authors: Karen L Swanson; C Michael Johnson; Udaya B S Prakash; Michael A McKusick; James C Andrews; Anthony W Stanson Journal: Chest Date: 2002-03 Impact factor: 9.410
Authors: Jacques Jougon; Michel Ballester; Frédéric Delcambre; Tarun Mac Bride; Philippe Valat; Francis Gomez; François Laurent; Jean François Velly Journal: Eur J Cardiothorac Surg Date: 2002-09 Impact factor: 4.191
Authors: Katerina D Samara; Dimitrios Tsetis; Katerina M Antoniou; Charalambos Protopapadakis; George Maltezakis; Nikolaos M Siafakas Journal: J Med Case Rep Date: 2011-02-10